$RNR Cashflow Statement | Understand Stock

$RNR

$341.22 -$10.44 (2.97%) Close

$RNR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows provided by (used in) operating activities
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Amortization, accretion and depreciation
Equity in undistributed (earnings) losses of other ventures
Net realized and unrealized (gains) losses on investments
Loss on sale of RenaissanceRe UK
Change in:
Premiums receivable
Prepaid reinsurance premiums
Reinsurance recoverable
Deferred acquisition costs and value of business acquired
Reserve for claims and claim expenses
Unearned premiums
Reinsurance balances payable
Other

Net cash provided by (used in) operating activities
Cash flows provided by (used in) investing activities
Proceeds from sales and maturities of fixed maturity investments trading
Purchases of fixed maturity investments trading
Net sales (purchases) of equity investments
Net sales (purchases) of short term investments
Net sales (purchases) of other investments
Proceeds from sales of short term investments
Purchases of short term investments
Proceeds from sales of equity investments
Purchases of equity investments
Proceeds from sales of other investments
Purchases of other investments
Proceeds from sales of investments in other ventures
Purchases of investments in other ventures
Return of investments in other ventures
Net sales (purchases) of other assets
Net proceeds from sale of RenaissanceRe UK
Net settlements of derivatives
Net purchase of Validus
Net cash provided by (used in) investing activities

Cash flows provided by (used in) financing activities
Dividends paid – RenaissanceRe common shares
Dividends paid – preference shares
RenaissanceRe common share repurchases
RenaissanceRe common share issuance, net of expenses
Repayment of debt
Issuance of debt, net of expenses
Repayment of Medici Revolving Credit Facility
Drawdown of Medici Revolving Credit Facility
Redemption of preference shares
Issuance of preference shares, net of expenses
Net third-party redeemable noncontrolling interest share transactions
Subscriptions of third-party redeemable noncontrolling interest shares
Redemptions of third-party redeemable noncontrolling interest shares
Total net third-party redeemable noncontrolling interest share transactions
Taxes paid on withholding shares
Net cash provided by (used in) financing activities
Effect of exchange rate changes on foreign currency cash
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental disclosure of cash flow information
Income taxes paid (refunded)
Interest paid
Non-cash consideration

Comments